Cortland Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $378K | Buy |
1,490
+1
| +0.1% | +$233 | 0.05% | 48 |
|
|
2026
Q1 | $364K | Sell |
1,489
-349
| -19% | -$81.3K | 0.05% | 45 |
|
|
2025
Q4 | $380K | Buy |
1,838
+1
| +0.1% | +$198 | 0.05% | 43 |
|
|
2025
Q3 | $341K | Sell |
1,837
-175
| -9% | -$30K | 0.04% | 54 |
|
|
2025
Q2 | $307K | Buy |
2,012
+1
| +0% | +$154 | 0.04% | 50 |
|
|
2025
Q1 | $333K | Buy |
2,011
+1
| +0% | +$156 | 0.04% | 43 |
|
|
2024
Q4 | $291K | Buy |
2,010
+2
| +0.1% | +$310 | 0.03% | 49 |
|
|
2024
Q3 | $325K | Buy |
2,008
+351
| +21% | +$55.9K | 0.04% | 45 |
|
|
2024
Q2 | $242K | Buy |
1,657
+1
| +0.1% | +$149 | 0.03% | 52 |
|
|
2024
Q1 | $262K | Sell |
1,656
-74
| -4% | -$11.8K | 0.03% | 50 |
|
|
2023
Q4 | $271K | Buy |
1,730
+1
| +0.1% | +$153 | 0.04% | 47 |
|
|
2023
Q3 | $269K | Sell |
1,729
-38
| -2% | -$6.27K | 0.04% | 45 |
|
|
2023
Q2 | $293K | Buy |
1,767
+1
| +0.1% | +$161 | 0.05% | 45 |
|
|
2023
Q1 | $274K | Sell |
1,766
-165
| -9% | -$26.6K | 0.04% | 47 |
|
|
2022
Q4 | $341K | Sell |
1,931
-79
| -4% | -$13.6K | 0.06% | 42 |
|
|
2022
Q3 | $328K | Buy |
2,010
+37
| +2% | +$6.26K | 0.06% | 43 |
|
|
2022
Q2 | $350K | Buy |
1,973
+164
| +9% | +$29.2K | 0.06% | 44 |
|
|
2022
Q1 | $321K | Sell |
1,809
-34
| -2% | -$5.79K | 0.04% | 47 |
|
|
2021
Q4 | $315K | Buy |
1,843
+35
| +2% | +$5.73K | 0.03% | 50 |
|
|
2021
Q3 | $292K | Buy |
1,808
+1
| +0.1% | +$171 | 0.03% | 53 |
|
|
2021
Q2 | $298K | Buy |
1,807
+153
| +9% | +$25.3K | 0.03% | 52 |
|
|
2021
Q1 | $272K | Hold |
1,654
| – | – | 0.03% | 52 |
|
|
2020
Q4 | $260K | Hold |
1,654
| – | – | 0.03% | 49 |
|
|
2020
Q3 | $246K | Hold |
1,654
| – | – | 0.03% | 50 |
|
|
2020
Q2 | $233K | Hold |
1,654
| – | – | 0.03% | 47 |
|
|
2020
Q1 | $217K | Sell |
1,654
-360
| -18% | -$51.1K | 0.04% | 44 |
|
|
2019
Q4 | $294K | Buy |
2,014
+317
| +19% | +$43K | 0.04% | 41 |
|
|
2019
Q3 | $220K | Sell |
1,697
-300
| -15% | -$39.5K | 0.04% | 44 |
|
|
2019
Q2 | $278K | Hold |
1,997
| – | – | 0.04% | 38 |
|
|
2019
Q1 | $279K | Sell |
1,997
-176
| -8% | -$23.6K | 0.05% | 41 |
|
|
2018
Q4 | $280K | Buy |
2,173
+90
| +4% | +$12.6K | 0.05% | 42 |
|
|
2018
Q3 | $288K | Sell |
2,083
-1,916
| -48% | -$255K | 0.04% | 45 |
|
|
2018
Q2 | $485K | Sell |
3,999
-15
| -0.4% | -$1.87K | 0.08% | 36 |
|
|
2018
Q1 | $514K | Hold |
4,014
| – | – | 0.09% | 31 |
|
|
2017
Q4 | $561K | Buy |
4,014
+600
| +18% | +$83.6K | 0.1% | 28 |
|
|
2017
Q3 | $444K | Sell |
3,414
-643
| -16% | -$85.2K | 0.08% | 36 |
|
|
2017
Q2 | $537K | Sell |
4,057
-45
| -1% | -$5.74K | 0.1% | 28 |
|
|
2017
Q1 | $511K | Sell |
4,102
-66
| -2% | -$7.88K | 0.1% | 34 |
|
|
2016
Q4 | $480K | Sell |
4,168
-70
| -2% | -$8.09K | 0.1% | 34 |
|
|
2016
Q3 | $501K | Sell |
4,238
-25
| -0.6% | -$3.03K | 0.1% | 36 |
|
|
2016
Q2 | $517K | Sell |
4,263
-80
| -2% | -$9.09K | 0.11% | 21 |
|
|
2016
Q1 | $470K | Buy |
4,343
+64
| +1% | +$6.63K | 0.1% | 22 |
|
|
2015
Q4 | $440K | Sell |
4,279
-311
| -7% | -$31.3K | 0.09% | 24 |
|
|
2015
Q3 | $428K | Hold |
4,590
| – | – | 0.1% | 24 |
|
|
2015
Q2 | $447K | Sell |
4,590
-114
| -2% | -$11.4K | 0.09% | 22 |
|
|
2015
Q1 | $473K | Hold |
4,704
| – | – | 0.1% | 22 |
|
|
2014
Q4 | $492K | Buy |
4,704
+1,080
| +30% | +$114K | 0.1% | 21 |
|
|
2014
Q3 | $386K | Buy |
3,624
+200
| +6% | +$20.7K | 0.09% | 23 |
|
|
2014
Q2 | $358K | Hold |
3,424
| – | – | 0.07% | 25 |
|
|
2014
Q1 | $336K | Sell |
3,424
-1,709
| -33% | -$158K | 0.07% | 26 |
|
|
2013
Q4 | $470K | Sell |
5,133
-126
| -2% | -$11.6K | 0.1% | 23 |
|
|
2013
Q3 | $456K | Hold |
5,259
| – | – | 0.1% | 23 |
|
|
2013
Q2 | $452K | Buy |
+5,259
| New | +$446K | 0.1% | 21 |
|
Other funds holding JNJ
Cortland Associates's JNJ Position: Q2 2026 in Review
Cortland Associates increased its Johnson & Johnson (JNJ) stake by 0.07% in Q2 2026, buying an estimated $233 and bringing the position to 1,490 shares worth $378K. The position accounts for 0.05% of the portfolio, ranked #48.
Cortland Associates first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $561K in Q4 2017. 2,639 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Cortland Associates held 1,490 shares of Johnson & Johnson worth $378K as of Q2 2026.
- Cortland Associates bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
- Johnson & Johnson made up 0.05% of Cortland Associates's portfolio in Q2 2026, its #48 holding.
- Cortland Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
- Cortland Associates's Johnson & Johnson position peaked at $561K in Q4 2017.
- 2,639 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Cortland Associates's 13F filing for Q2 2026, filed 28 Jul 2026.